Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma, Non-Small-Cell Lung × toripalimab × Clear all

Phase

Phase 2 15 Phase 1/2 4 Phase 1 4 Phase NA 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 11 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Transitional Cell 3 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Hepatocellular 2 Triple Negative Breast Neoplasms 1 Treatment-naive Advanced Non-small Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Recurrence 1 Radiotherapy 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Locally Advanced or Metastatic GC and GCJ Adenocarcinoma 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Cholangiocarcinoma 1 Cervical Cancer Metastatic 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Carboplatin 162 Cisplatin 133 Pemetrexed 125 Paclitaxel 108 Docetaxel 92 pembrolizumab 75 Gemcitabine 57 Erlotinib Hydrochloride 42 Radiotherapy 35 durvalumab 29 Gefitinib 29 Vinorelbine 26 Bevacizumab 24 Nivolumab 22 Drug Therapy 21 atezolizumab 18 130-nm albumin-bound paclitaxel 16 osimertinib 15 tislelizumab 14 Radiosurgery 13 Crizotinib 13 Etoposide 12 Afatinib 10 aumolertinib 9 Surgical Procedures, Operative 9 Albumin-Bound Paclitaxel 9 icotinib 8 Specimen Handling 8 Observation 8 Ipilimumab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06437977 2025-03-13

neoR-TORCH

Shanghai Chest Hospital

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡